[Topical use of lysostaphin for Staphylococcus aureus infection of burn wounds in mice].
The effect of lysostaphin on the burn wounds infected with Staphylococcus aureus was studied in mice. The results showed that the mortality and incidence of bacterial isolation in wounds were 17.2% and 8.3%, respectively, in mice treated by lysostaphin, and the figures were significantly lower than that treated by SD-Ag (40.6% and 100%) or base (44.1% and 94.7%). In lysostaphin group the bacterial count of subeschar tissue was 1325 cfu/g, compared with more than 10(9) cfu/g in both SD-Ag and base groups. The results demonstrate that lysostaphin has powerful killing effect on S. aureus, and may be used as atopical antimicrobial to control burn wound infection with S. aureus.
Huan
J N
JN
Trauma and Burn Institute, Changhai Hospital, Shanghai.
D000818:Animals; D002056:Burns / Q000382:microbiology*; D015169:Colony Count, Microbial; D005260:Female; D008248:Lysostaphin / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000254:growth & development; D014946:Wound Infection / Q000188:drug therapy* / Q000382:microbiology
D008248:Lysostaphin